Category Archives: AUSTRALIAN HEALTH CARE STOCK

Why we think Somnomed Limited shares can soar higher?

Strong Q4 growth across geographies: SomnoMed Limited (ASX: SOM) reported strong sales in the US during the quarter (+24% over prior year), combined with ongoing strong Q4 growth in Europe (+20.6%), resulted in record total group unit quarterly sales of 19,859 units (+24.2%). Total device sales for the FY17 stood at 68,100 units. Unaudited quarterly group revenues grew by 22%

Read more

Japara Healthcare Ltd (ASX: JHC) has bought four new land purchases in FY17 and built 445 new greenfield beds in the anticipation.

Japara Healthcare Ltd (ASX: JHC) has bought four new land purchases in FY17 and built 445 new greenfield beds in the anticipation. During H1FY17, JHC had reported a revenue growth of 14.5% year on year (yoy) to $178.5 million while EBITDA grew by 3.6% yoy to $29.1 million. However, it has witnessed a decline of 9.9% yoy in net profit

Read more

2 ways you can profit from Australia‚Äôs ageing population – Japara Healthcare and Ramsay Health care

Japara Healthcare Ltd (ASX: JHC) has bought four new land purchases in FY17 and built 445 new greenfield beds in the anticipation. During H1FY17, JHC had reported a revenue growth of 14.5% year on year (yoy) to $178.5 million while EBITDA grew by 3.6% yoy to $29.1 million. However, it has witnessed a decline of 9.9% yoy in net profit

Read more

Primary Healthcare – Profits at the lower end

Following a review of its unaudited results for FY 2017, Primary Health Care Limited (ASX:PRY) has confirmed guidance for FY 2017 at the lower end of its previous range at $92 million Underlying NPAT. A decline in Medical centers underlying EBIT performance is expected to be partially offset by a robust performance in Imaging, a modest increase in Pathology on

Read more

Recently, Sirtex Medical Limited presented the SIRFLOX/FOXFIRE Global right-side survival data in metastatic colorectal cancer (MCRC)

Recently, Sirtex Medical Limited (ASX:SRX) presented the SIRFLOX/FOXFIRE Global right-side survival data in metastatic colorectal cancer (mCRC) at the 19th European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer (WCGIC) in Barcelona, Spain. The combined SIRFLOX and FOXFIRE Global studies (n=530 and n=209, respectively) showed that for patients with a right-sided primary tumor, median Overall Survival (OS) was

Read more

Time to sell Ansell

Recently, the group has executed a binding agreement for the sale of its Sexual Wellness (SW) business for US$600m to Humanwell Healthcare and CITIC Capital China Partners (Buyer Consortium), and the transaction is expected to get completed by the end of September 2017. Net after-tax cash proceeds to Ansell are expected to be approximately US$529m and the company also expects

Read more
« Older Entries